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Abstract
Following infection, the balance between protective immunity and immunopathology often
depends on the initial infectious load. Several studies have investigated the effect of infec-
tious dose; however, the mechanism by which infectious dose affects disease outcomes
and the development of a protective immune response is not known. The aim of this study
was to investigate how the infectious dose modulates the local and systemic humoral and
the cellular immune responses during primary ocular chlamydial infection in the guinea pig
animal model. Guinea pigs were infected by ocular instillation of a Chlamydophila caviae-
containing eye solution in the conjunctival sac in three different doses: 1×102, 1×104, and
1×106 inclusion forming units (IFUs). Ocular pathology, chlamydial clearance, local and sys-
temic C. caviae-specific humoral and cellular immune responses were assessed. All inocula
of C. caviae significantly enhanced the local production of C. caviae-specific IgA in tears,
but only guinea pigs infected with the higher doses showed significant changes in C. caviae-
specific IgA levels in vaginal washes and serum. On complete resolution of infection, the low
dose of C. caviae did not alter the ratio of CD4+ and CD8+ cells within guinea pigs’ subman-
dibular lymph node (SMLN) lymphocytes while the higher doses increased the percentages
of CD4+ and CD8+ cells within the SMLN lymphocytes. A significant negative correlation
between pathology intensity and the percentage of CD4+ and CD8+ cells within SMLN lym-
phocyte pool at selected time points post-infection was recorded for both 1×104, and 1×106
IFU infected guinea pigs. The relevance of the observed dose-dependent differences on the
immune response should be further investigated in repeated ocular chlamydial infections.
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Introduction
Almost six million people are blind or visually impaired due to trachoma caused by the obli-
gate intracellular bacterium Chlamydia trachomatis (Ct) serovars A–C, which is the most
common infectious cause of blindness worldwide [1–4]. In trachoma-endemic communities,
the prevalence of ocular Ct infection decreases with age, and the highest bacterial loads are
found in young children, suggesting that a degree of protective immunity develops following
natural infection [5]. The clinical outcomes of ocular Ct infection range from no inflamma-
tion/disease to severe and sight-threatening sequelae, raising questions on the nature of host-
pathogen interactions. The key question is why only a minority of people living in trachoma-
endemic regions develop severe scarring complications. The likely explanation is the interplay
between the lifetime burden of infection among individuals and their local immune response.
The immunological basis of scarring trachoma is not well understood; whether it is driven
primarily through cell-mediated adaptive or epithelial cell-derived innate responses is unclear
[6]. Moreover, the balance between protective immunity and immunopathology may depend
on the initial infectious load. It has already been shown that Ct dose affects the balance of B-/
T-cell responses in vitro [7].
Inclusion conjunctivitis, an ocular infection caused by Chlamydophila caviae in guinea pigs,
is a well-characterized and accessible model for studying trachoma [8, 9]. C. caviae infection in
guinea pigs closely resembles the disease process of ocular Ct infection in humans [10]. Guinea
pigs are naturally infected with the chlamydial species, C. caviae. Murray first isolated C. caviae
from the infected conjunctivae of young laboratory guinea pigs and defined it as the causative
agent of guinea pig inclusion conjunctivitis [11]. The infection of guinea pigs with human Ct
serovars D and E [12], and the usage of this model for Ct vaccination studies [13], was
described in the genital, but not in the ocular, animal model. The major disadvantage of the
ocular guinea pig model has been the lack of a wide range of immunological reagents/consum-
ables, knockout animals, and easily accessible inbred guinea pig strains. Recently, a novel
guinea pig gene expression RT-qPCR array was developed, which might advance the utilisa-
tion of the guinea pig model and help to better our understanding of the immune responses
after infection/immunisation with Chlamydiae [14].
Researchers were able to characterise important aspects of disease progression and protec-
tion in the guinea pig ocular model, mostly in repeated infections: i) complete or marked
reduction in the intensity of infection upon reinfection [11, 15], ii) the development of cell-
mediated immunity demonstrating that a trachoma-like disease could be elicited by repeated
infections [16], and iii) enhancement of the local and serum antibody responses against Chla-
mydiae as a result of infection and reinfection [17]. In our previous study, we examined the
effect of infectious dose on host response in repeated infections [18].
The effect of infectious dose on ocular infection kinetics and the resulting pathologic
responses using the guinea pig ocular inclusion conjunctivitis model [8, 19] were described in
primary ocular chlamydial infection [8], but no profiling of immune responses after the onset
of infection was performed. Lacy et al. used primary ocular infection with C. caviae to investi-
gate whether acute inflammation had a role in modulating the adaptive immune response
[20], although the experiments were performed using only one dose: 1×104 inclusion-forming
units (IFU). The study successfully determined the essential role of neutrophils in the immu-
nopathology of primary chlamydial infections.
The importance of infectious dose was also proven in other chlamydial animal models. It
has been demonstrated that earlier onset of infection is dose dependent; death of the subject at
higher doses and survival at lower doses for respiratory infections with C. muridarum have
been reported [21]. It has also been shown that the infectious dose of C. muridarum affects
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both the rate and extent of clearance and ascension in the female reproductive tract, as well as
the development of gross pathology [22]. Furthermore, the infectious dose of C. muridarum
modulates the innate immune response and ascending infection [23]. Earlier onset of infection
with increased peak levels of organisms in guinea pig infections with C. caviae have also been
reported [24]. Recent studies involving calves intra-bronchially infected with different doses of
C. psittaci resulted in dose-dependent pulmonary and systemic host reactions, ranging from
mild to severe forms [25]. Intranasal infection with a low/medium dose of C. abortus in non-
pregnant sheep results in a latent infection that leads to infection of the placenta and abortion
in a subsequent pregnancy. In contrast, a high dose stimulates protective immunity, resulting
in a much lower abortion rate [26].
Doses used so far in studies investigating the immune responses in primary ocular chla-
mydial infection models of 1×104 IFU and above were shown to induce exaggerated ocular
pathology. It is not known whether these doses are relevant in the “real life” situation. In the
guinea pig genital chlamydial infection model the natural infectious dose was determined as
1×102 IFU [24]. Therefore, we infected guinea pigs with a 102 IFU dose to induce ocular infec-
tion and compared low (1×102), moderate (1×104) and high (1×106) doses to determine the




The experiments were approved by the ‘‘Ethics Committee for the Welfare of Experimental
Animals” at the Institute of Virology, Vaccines and Sera–Torlak, conformed to the Serbian laws
and European regulations on animal welfare (Approval No. 323-07-01577/2016-05/12), and
adhered to the Association for Research in Vision and Ophthalmology Statement for the Use of
Animals in Ophthalmic and Vision Research. All animals were handled in strict accordance
with good animal practice as defined by the Serbian code of practice (published in Službeni
Glasnik No. 41/9) for the care and use of animals for scientific purposes, the Guide for the Care
and Use of Laboratory Animals of the Torlak Institute (2133/1, 21. 04. 2011), and the Basel Dec-
laration that is committed to the 3R principle (replace, reduce, refine). Animal testing was
planned and carried out with extreme care. Every effort was made to minimise animal suffer-
ing. The guinea pigs were observed daily by trained animal care staff, and animals requiring
care were referred to the attending veterinary surgeon for immediate care. Terminal euthanasia
was carried out by lethal CO2 overdose. We did not observe any unexpected deaths of animals
during this study, nor were there any severe incidents that required euthanasia of an animal.
Experimental animals
Female Hartley strain guinea pigs weighing 300–350 g, and 6 weeks of age were used in this
study. Each group included 5 animals (5 animals per group for each infectious dose at the
defined time point), with 85 animals in total. Animals were housed individually in cages with
filter tops, given food and water ad libitum, and kept on a 12-h light/12-h dark cycle. The
guinea pigs were pre-screened by in-house optimised enzyme-linked immunosorbent assay
(ELISA) as previously described [18].
Chlamydia strain and conjunctival infections
C. caviae, guinea pig inclusion conjunctivitis strain, was kindly provided by Prof. Roger G.
Rank, prepared in his laboratory through continuous passage, first in yolk sac and then in
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tissue culture. Stocks of C. caviae were produced according to standard methodology [27] in
McCoy cells and frozen at -80˚C in sucrose-phosphate-glutamate (SPG) buffer until needed.
The animals were anaesthetized intramuscularly with a mixture of ketamine (30 mg/kg) and
xylazine (2 mg/kg). Inoculation was performed on day 0 on the anaesthetised guinea pigs by
instilling 25 μl of SPG buffer containing 1×102, 1×104, and 1×106 IFU of C. caviae directly into
the conjunctival sac with a micropipette, while the control group received SPG buffer only.
Only one eye of each animal was inoculated with C. caviae. The doses were chosen according
to previously established criteria: i) high dose (1×106 IFU) ensures aggravated ocular disease
[28], ii) moderate dose (1×104 IFU) ensures 100% infection in all animals, with a pathology
response that can be easily quantified by gross observation [20], and iii) low dose (1×102 IFU)
approximates natural genital infection in guinea pigs [24]. These three doses of C. caviae have
previously been used to induce ocular infection in guinea pigs, and there have been no reports
of visual disability [8, 19]. Our experimental procedure did not cause any visual impairment in
the guinea pigs, and visual examinations were continually performed over the post-infection
period. None of the applied doses caused changes in behavioural patterns in the treated ani-
mals relative to their respective controls or disrupted their normal daily activity. The guinea
pigs were sacrificed on days 4, 7, 14 and 21 post-infection (abbreviated as dpi4, dpi7, dpi14,
and dpi21, respectively). Blood, conjunctival swabs, tears, vaginal washes, and lymph nodes
were taken for further analysis. The schedule of monitoring and sample collection during the
post-infection period is described in Fig 1.
Pathology scoring
A trained ophthalmologist who was blinded to the experimental groups examined the guinea
pigs’ eyes daily by visual scoring of gross ocular pathology. The palpebral and bulbar conjunc-
tivae were evaluated for erythema, oedema, and exudation in each animal. Each observation
was classified into 5 categories: (0.5) trace pathologic response, (1) slight erythema or oedema
of either the palpebral or bulbar conjunctiva, (2) definite erythema or oedema of either the pal-
pebral or bulbar conjunctiva, (3) definite erythema or oedema of both the palpebral and bulbar
conjunctiva, or (4) definite erythema or oedema of both the palpebral and bulbar conjunctiva
plus the presence of exudate.
Isolation of Chlamydia from conjunctival swabs
Conjunctival swabs for the isolation and quantification of C. caviae were collected from the
guinea pigs while under ketamine/xylazine anaesthesia. Conjunctival swabs were collected
with the Copan Universal Transport Medium (UTM-RT) System (Copan Italia, Brescia, Italy)
and frozen at -80˚C until needed. The numbers of IFU were determined by culture in McCoy
cells, as previously described [29]. In brief, McCoy cell monolayers were infected with swab
material using centrifugation, and the infection was stopped after 24 hours with 100% metha-
nol fixation. C. caviae IFUs were visualised by staining with a fluorescein isothiocyanate
(FITC)-conjugated monoclonal antibody against chlamydial lipopolysaccharide (Clone B410F,
Pierce Biotechnology, Rockford, IL, USA). IFUs were counted using a fluorescence micro-
scope (Axio Observer Zeiss, Vienna, Austria).
Myeloperoxidase immunohistochemistry
Immunohistochemical staining for myeloperoxidase, a neutrophil-specific enzyme, was per-
formed on 3 μm paraffin-embedded conjunctival sections. A rabbit polyclonal antibody to
myeloperoxidase (Sigma-Aldrich, Germany), followed by anti-rabbit IgG-biotin (Sigma-
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Aldrich, Germany) and ExtrAvidin1−Peroxidase (Sigma-Aldrich, Germany) were used.
Detection was performed with 3,30-diaminobenzidine (DAB) (DAKO, Denmark).
Determination of C. caviae-specific antibody response
Peripheral blood samples were taken from the lateral saphenous veins while the guinea pigs
were under anaesthesia. Serum samples, tears, and vaginal washes were collected on day 0
(prior to each infection) and on dpi4, dpi7, dpi14, and dpi21. ELISA was performed to quantify
the C. caviae specific IgG levels in serum samples. To measure C. caviae specific IgA levels in
samples, ELISA plates (MaxiSorp™) (Nalge Nunc International, Roskilde, Denmark) were
coated (50 μl/well) with Renografin-purified C. caviae elementary bodies (EB; 1×106 EBs/ml in
SPG buffer) and incubated overnight at 4˚C. The next day, 2% (w/v) bovine serum albumin in
phosphate-buffered saline (BSA/PBS) was added as a blocking reagent for 2 h at a room tem-
perature (RT) of 21˚C. This blocking step and all subsequent ELISA steps were followed by a
wash with 0.05% (v/v) Tween-20 in PBS (four times, 200 μl/well). Sera (1:100), tears (1:24),
and vaginal washes (1:24) from individual animals were each diluted in 1% (w/v) BSA/PBS
and added to the wells in duplicate. The samples were incubated on the plates for 2 h at 37˚C.
Antigen-specific antibody binding was detected after a 1-h incubation at RT using anti-guinea
pig IgA (MyBioSource, San Diego, CA, USA) at a 1:800 dilution in 1% (w/v) BSA/PBS. Fur-
thermore, a dilution of 1:20,000 of peroxidase-conjugated anti-sheep IgG antibody (Sigma-
Aldrich, St. Louis, MO, USA) in 1% (w/v) BSA/PBS was added to each well. After a 1-h incuba-
tion at RT, the antigen-antibody interactions were visualised using 3,3’,5,5’-tetramethylbenzi-
dine (TMB) substrate (eBioscience, San Diego, CA, USA). Colour development was stopped
within 30 min by adding 2 M sulphuric acid, and absorbance values were measured at 450 and
650 nm.
Proliferation assay
Submandibular lymph node (SMLN) cells were isolated and prepared, as previously described,
[30] and stimulated with 1×106 IFU/ml live C. caviae EBs. Cell Counting Kit-8 reagent (CCK8)
(Sigma-Aldrich, Germany) was used to quantify the number of viable cells in proliferation
according to the manufacturer’s instructions. In brief, 10 μl/well of CCK8 was added after 48 h
of incubation, and the cells were incubated for a further 4 h. The reaction was stopped by the
addition of 1% (w/v) sodium dodecyl sulphate (10 μl/well), and absorbance values were mea-
sured at 450/650 nm (A450/650) using a spectrophotometer (Ascent 6–384 [Suomi]) (MTX Lab
Fig 1. Experimental design. Guinea pigs were infected on day 0 via inoculation of 1×102, 1×104 or 1×106 IFUs of C. caviae
directly into the conjunctival sac (arrow). Pathological signs were followed daily for 21 days post-infection (dashed line). Days 4, 7,
14 and 21 post-infection are chosen as time points when sampling of mucosal washes, sera and swabs were performed, and ex
vivo analyses were performed (asterisks).
https://doi.org/10.1371/journal.pone.0180551.g001
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Systems Inc., Vienna, VA, USA). The number of viable cells per well was calculated using a
standard curve A450/650 = f (number of cells). A discrete pool of non-stimulated cells (the viable
cells count determined by trypan blue dye exclusion) was measured using an Invitrogen™
Countess™ Automated Cell Counter and used to produce a standard curve. A proliferation
index (PI) for each specifically stimulated cell suspension was calculated for each animal. Pre-
suming that stimulation did not affect the transformation rate of CCK8 and that number of
viable cells was changed upon stimulation due to cell proliferation, the PI index was calculated
as the ratio of the number of viable cells per well present in stimulated (Ss) cultures to the
number of viable cells per well present in the corresponding non-stimulated (So) cultures
(PI = Ss/So).
Flow cytometry
SMLN cells (1×106 cells/sample) were immunostained using fluorochrome-conjugated anti-
bodies specific for guinea pig CD4 (PE-conjugated, BioRad-AbDSerotec) and CD8 (FITC-
conjugated, BioRad-AbDSerotec). Prior to staining, the cells were washed with a cold 2% BSA/
0.1% NaN3/PBS solution (2× centrifugation at 300 g, 5 min, 4˚C). Fluorochrome-conjugated
antibodies were added to the resuspended cell pellets and incubated in the dark for 30 min at
4˚C. Discrete aliquots of each analysed cell suspension were incubated with the corresponding
isotype control antibodies and used as an unstained reference for setting the analysis staining
thresholds. Unbound antibodies were removed by washing in cold 2% BSA/0.1% NaN3/PBS
solution (3× centrifugation at 300 g, 5 min, 4˚C). Lymphocytes were gated per their position
within forward scatter vs. side scatter plots and analysed for the percentage of CD4+ and CD8+
cells using the BD FACSVerse™ flow cytometer (BD Biosciences). BD CellQuest™ Pro software
was used for analysis.
Statistics
The statistical significance of the observed differences was evaluated using a two-way ANOVA
test followed by Tukey’s multiple comparisons test. A bivariate Pearson correlation analysis
was used to analyse the correlation. All statistical analyses were performed with GraphPad
Prism 6.0 (GraphPad Inc., La Jolla, CA, USA). A probability (P) value of 0.05 was set as the sig-
nificance threshold.
Results
Infectious dose influences the dynamics of pathology during primary C.
caviae infection
Monitoring of ocular pathology in guinea pigs infected by the topical inoculation of C. caviae
at three different doses revealed that the infectious dose influences the intensity of the pathol-
ogy and the dynamics of pathology development. In guinea pigs inoculated with 1×102 and
1×104 IFU, pathology scores peaked at dpi7 and were significantly higher compared to the
pathology scores recorded for corresponding (inoculated with an equal dose) animals at any
other time point (Fig 2A). Furthermore, the pathology scores recorded on dpi4 and dpi7 for
guinea pigs inoculated with 1×104 IFU were significantly higher than those recorded at the
same time points for guinea pigs inoculated with 1×102 IFU (dpi4 P<0.05; dpi7 P<0.001).
In guinea pigs inoculated with 1×106 IFU, an intensive ocular pathology was marked earlier
(on dpi4) compared to those inoculated with 1×102 and 1×104 IFU (pathology scores on dpi4:
1×106 IFU vs. 1×102 IFU, P<0.001; 1×106 IFU vs. 1×104 IFU, P<0.05). Furthermore,
Infectious dose modulates immune responses in chlamydial infection
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Fig 2. Ocular pathology scores (A) and C. caviae load (B) in guinea pigs infected with a single ocular
instillation of three different C. caviae doses. The amount of C. caviae applied per guinea pig eye
(expressed as IFU) and screening time points within the post-infection period (day 4 –dpi4, day 7 –dpi7, day
14 –dpi14, and day 21 –dpi21) are indicated on the x-axis. The start of infection is considered as day 0. Age-
matched non-infected guinea pigs (nc) were used as negative controls. Statistical significance of the observed
differences was evaluated using two-way ANOVA test followed by Tukey’s multiple comparisons test. The
statistical significance of differences in parameter values between specific time points (compared groups
indicated with arrows) for guinea pigs infected with an equal amount of C. caviae is indicated as follows: *
P<0.05, ** P<0.005, and *** P<0.001.
https://doi.org/10.1371/journal.pone.0180551.g002
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pathology scores recorded in the guinea pigs inoculated with 1×106 IFU on dpi4 and dpi7
were not significantly different from those recorded in guinea pigs inoculated with 1×104 IFU
on dpi7.
Bivariate Pearson’s correlation analysis showed a significantly positive correlation between
the C. caviae burden (Fig 2B) and pathology severity (Fig 2A; Pearson’s correlation coefficient
(Pcc) = 0.857, P<0.001). The correlation was most prominent in guinea pigs inoculated with
1×104 and 1×106 IFU (1×102 IFU: Pcc = -0.192, P>0.05; 1×104 IFU: Pcc = 0.853, P<0.001;
1×106 IFU: Pcc = 0.824, P<0.001).
Influx of neutrophils into the conjunctiva and conjunctiva-associated
lymphoid tissue after C. caviae infection is dose dependent
A dose-dependent increase in neutrophil infiltration into the conjunctival tissue was evident
in the infected animals (Fig 3). Guinea pigs inoculated with 1×104 and 1×106 IFU showed
more neutrophils in the deeper layers of the conjunctiva and conjunctiva-associated lymphoid
tissue (CALT). The strongest neutrophil infiltration of the conjunctival tissue was observed on
dpi4 in animals inoculated with 1×106 IFU. At lower infectious doses, more neutrophils were
observed on dpi7. The overall damage to the conjunctival epithelium in the infected animals
was comparable for 1×106 and 1×104 IFU inoculated animals and more severe in these two
groups compared to the 1×102 IFU inoculated group. Non-infected animals showed normal
conjunctival morphology throughout the experiment. A comparison of changes in the number
of neutrophils within infected conjunctiva and CALT (Fig 3) with changes in pathology sever-
ity post-infection (Fig 2A), showed that the influx of neutrophils was positively correlated with
pathology scores.
C. caviae infectious dose affects levels of IgA-mediated humoral
immune response
The changes in C. caviae-specific IgA levels for different infectious doses of C. caviae were
examined in tears (Fig 4A) and in vaginal washes (Fig 4B). All used inoculation doses signifi-
cantly enhanced the local production of C. caviae-specific IgA (Fig 4A). The maximum local
production of C. caviae-specific IgA was recorded on dpi4 (vs. negative control (nc): P<0.05
for 1×102 IFU and 1×104 and P<0.005 for 1×106 IFU) and gradually decreased during the
post-infection follow-up period (vs. nc: on dpi7 and dpi14 P<0.05, and on dpi21 P>0.05 for
all infected groups). C. caviae-specific IgA levels in vaginal washes were found to be signifi-
cantly elevated during the post-infection period only in guinea pigs inoculated with 1×106 IFU
(Fig 4B). The highest concentration of C. caviae-specific IgA in vaginal washes from 1×106
IFU inoculated guinea pigs was recorded on dpi14. IgA levels from the animals inoculated
with 1×106 IFU of C. caviae were significantly higher than IgA levels in vaginal washes from
the control non-infected animals (P<0.05) and vaginal washes taken on dpi14 from animals
inoculated with 1×102 IFU of C. caviae (P<0.05).
The sera of infected guinea pigs were also analysed for levels of C. caviae-specific antibodies,
IgA and IgG. Our results revealed that a greater variation in C. caviae-specific antibody levels
was associated with higher inoculation doses. The rise of C. caviae-specific IgA levels in the
serum, up to dpi14, was statistically significant only in guinea pigs inoculated with 1×106 IFU
(Fig 5A). The levels of C. caviae-specific serum IgA recorded on dpi14 were significantly
higher for guinea pigs inoculated with 1×106 IFU than for those inoculated with lower doses of
C. caviae (1×102 IFU and 1×104 IFU, P<0.05).
A significant rise in the levels of C. caviae-specific IgG in the sera of all infected guinea pigs
was present on dpi14 (Fig 5B); the highest levels of C. caviae-specific IgG were recorded in the
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sera of guinea pigs inoculated with 1×106 IFU of C. caviae (dpi14: 1×106 IFU vs. 1×102 IFU,
P<0.001; 1×106 IFU vs. 1×104 IFU, P<0.05; 1×104 IFU vs. 1×102 IFU, P<0.005). The rise of C.
caviae-specific IgG level in the sera of the guinea pigs inoculated with 1×104 IFU and 1×106
IFU continued after dpi14 with the highest level being recorded at the end of the follow-up
period (dpi21: 1×106 IFU vs. 1×104 IFU, P>0.05).
Fig 3. The abundance of neutrophils in the conjunctiva and CALT of guinea pigs infected with a single ocular instillation
of three different C. caviae doses. The neutrophils infiltration was evaluated in paraffin-embedded conjunctival sections by
immunohistochemical staining for myeloperoxidase, a neutrophil-specific enzyme. Conjunctival sections were prepared from
samples collected at screening time points within the post-infection period (day 4 –dpi4, day 7 –dpi7, day 14 –dpi14, day 21 –dpi21).
ExtrAvidin®−Peroxidase/DAB system was used for visualisation of myeloperoxidase presence.
https://doi.org/10.1371/journal.pone.0180551.g003
Infectious dose modulates immune responses in chlamydial infection
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Fig 4. The levels of C. caviae-specific IgA in tears (A) and vaginal washes (B) of guinea pigs infected
with a single ocular instillation of three different C. caviae doses. The amount of C. caviae applied per
guinea pig eye (expressed in IFU) and screening time points within the post-infection period (day 4 –dpi4, day
7 –dpi7, day 14 –dpi14, day 21 –dpi21) are indicated on the x-axis. The start of infection is considered as day
0. Age-matched non-infected guinea pigs (nc) were used as negative controls. The level of specific antibodies
is expressed as a relative concentration, calculated as the A450/650 for a sample divided by the lowest A450/650
recorded within the same assay for the corresponding nc sample. The statistical significance of the observed
Infectious dose modulates immune responses in chlamydial infection
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Responsiveness to C. caviae stimulation varies during the post-infection
period but is not significantly influenced by the C. caviae infectious dose
The proliferative response analyses of SMLN cells (Fig 6) collected on dpi4 from the guinea
pigs inoculated with 1×102 IFU revealed no significant increase in their responsiveness in
comparison with corresponding cells collected from non-infected control guinea pigs. Fur-
thermore, compared to the SMLN cells from the 1×102 IFU inoculated guinea pigs, the respon-
siveness of SMLN cells to C. caviae in vitro stimulation was lower for both the 1×104 IFU
(P<0.05) and 1×106 IFU (P<0.05) inoculated guinea pigs during the early post-infection
period (on dpi4). Bivariate Pearson’s correlation analysis performed for all guinea pigs infected
with C. caviae showed a negative correlation between the pathology scores recorded on dpi4
and proliferative responses to C. caviae in vitro stimulation recorded for the corresponding
(from the same animal) SMLN taken at the same time point (pathology score vs. SMLN PI:
Pcc = -0.667, P = 0.001). SMLN cells collected from the 1×104 IFU and 1×106 IFU inoculated
guinea pigs on dpi7 showed a greater proliferation after stimulation with C. caviae compared
to the corresponding cultures of cells collected on dpi4 (P<0.05 for 1×104 IFU inoculated
guinea pigs). After dpi7, the SMLN cell responsiveness from the 1×104 IFU inoculated guinea
pigs to in vitro stimulation with C. caviae gradually decreased. In the 1×106 IFU inoculated
guinea pigs the SMLN cell responsiveness on dpi7 and dpi14 remained at the same level and
then dropped to the nc values on dpi21.
Variations in the numbers of CD4+ and CD8+ cells within SMLN
lymphocytes during the post-infection period depends on C. caviae
infectious dose
Analysis of the percentage of CD4+ and CD8+ cells in SMLN lymphocytes infected with C.
caviae via the ocular mucosa revealed no significant variation in the 1×102 IFU inoculated ani-
mals (Fig 7). However, there were significant changes in the percentages of CD4+ and CD8+
cells in the guinea pigs inoculated with 1×104 IFU and 1×106 IFU, and the pattern alterations
were comparable for both doses. The lowest percentages of CD4+ and CD8+ lymphocytes in
the SMLNs of 1×104 IFU and 1×106 IFU inoculated guinea pigs were recorded on dpi7. Com-
pared to the samples collected from non-infected control guinea pigs, the decrease in the per-
centages of CD8+ cells within the SMLN lymphocyte population was statistically significant for
both groups (P<0.05) while the reduction in the percentage of CD4+ lymphocytes was not sta-
tistically significant in either group.
The highest percentages of both CD4+ and CD8+ within the SMLN of the 1×104 IFU and
1×106 IFU inoculated guinea pigs were recorded upon complete resolution of infection, on
dpi21, and were significantly higher (P<0.05) compared to those of non-infected controls.
Furthermore, over the whole post-infection period there was a negative correlation between
pathology intensity and percentages of CD4+ and CD8+ within SMLN lymphocyte pool for
both 1×104 IFU (pathology score vs. CD4+ Pcc = -0.598, P = 0.005; pathology score vs. CD8+
Pcc = -0.679, P = 0.001) and 1×106 IFU inoculated (pathology score vs. CD4+ Pcc = -0.462,
P<0.05; pathology score vs. CD8+ Pcc = -0.637, P<0.005) guinea pigs.
differences was evaluated using the two-way ANOVA test followed by Tukey’s multiple comparisons test. The
statistical significance of the differences in parameter values between specific time points (compared groups
indicated with arrows) for guinea pigs infected with an equal amount of C. caviae is indicated as follows: *
P<0.05, ** P<0.005, and *** P<0.001.
https://doi.org/10.1371/journal.pone.0180551.g004
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Fig 5. The levels of C. caviae-specific IgA (A) and IgG (B) in the sera of guinea pigs infected with a
single ocular instillation of three different C. caviae doses. The amount of C. caviae applied per guinea
pig eye (expressed in IFU) and screening time points within post-infection period (day 4 –dpi4, day 7 –dpi7,
day 14 –dpi14, and day 21 –dpi21) are indicated on the x-axis. The start of infection is considered as day 0.
Age-matched non-infected guinea pigs (nc) were used as negative controls. The level of specific antibodies is
expressed as a relative concentration, calculated as the A450/650 for a sample divided by the lowest A450/650
recorded within the same assay for the corresponding nc sample. The statistical significance of the observed
Infectious dose modulates immune responses in chlamydial infection
PLOS ONE | https://doi.org/10.1371/journal.pone.0180551 July 5, 2017 12 / 20
Discussion
We have demonstrated using three different doses of C. caviae that the infectious dose affects
the levels of specific IgA-mediated humoral immune response as well as the changes in the per-
centages of CD4+ and CD8+ cells within SMLN lymphocytes during the post-infection period
in an ocular guinea pig model.
differences was evaluated using the two-way ANOVA test followed by Tukey’s multiple comparisons test. The
statistical significance of differences in parameter values between specific time points (compared groups
indicated with arrows) for guinea pigs infected with an equal amount of C. caviae is indicated as follows: *
P<0.05, ** P<0.005, and *** P<0.001.
https://doi.org/10.1371/journal.pone.0180551.g005
Fig 6. Proliferation of SMLN cells after stimulation with live C. caviae. Cell cultures were prepared from SMLN and spleen cells
collected at defined time points (post-infection: day 4 –dpi4, day 7 –dpi7, day 14 –dpi14, and day 21 –dpi21) from guinea pigs infected with
C. caviae (infectious doses per eye, expressed in IFU, assigned on x-axes) and age-matched non-infected guinea pigs (nc; used as
negative controls). The start of infection is considered as day 0. The PI is calculated per individual sample and defined as a ratio of number
of viable cells per well present in a stimulated culture to the number of viable cells per well present in the corresponding non-stimulated
culture. The statistical significance of the observed differences was evaluated using the two-way ANOVA test followed by Tukey’s multiple
comparisons test. The statistical significance of the differences in parameter values between specific time points (compared groups
indicated with arrows) for guinea pigs infected with an equal amount of C. caviae is indicated as follows: * P<0.05, ** P<0.005, and ***
P<0.001.
https://doi.org/10.1371/journal.pone.0180551.g006
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Consistent with previous studies [8, 19], we have shown that the C. caviae dose influences
the kinetics of chlamydial infection and the resulting gross pathologic findings with moderate
(1×104 IFU) and low (1×102 IFU) doses, increasing the time to the peak of infection.
It is known that B cells play an important role in immunity to chlamydial infection in
the mouse [31] and guinea pig model of chlamydial genital infection [32, 33]. The role of
IgA in protective immunity is supported by in vitro studies showing the neutralising
Fig 7. Expression of CD4 and CD8 on SMLN lymphocytes. Cell suspension for BD FACSVerse™ analyses were prepared from
SMLN and splenic lymphocytes collected at defined time points (post-infection: day 4 –dpi4, day 7 –dpi7, day 14 –dpi14, and day 21 –
dpi21) from guinea pigs infected with C. caviae (infectious doses per eye, expressed in IFU, assigned on the x-axis) and age-matched
non-infected guinea pigs (nc; used negative controls). The start of infection is considered as day 0. The expression of CD4 and CD8 are
presented as percentages of CD4+ and CD8+ cells within lymphocyte gates, respectively. Lymphocytes were gated according to their
position within the forward scatter vs. side scatter plot. The statistical significance of the observed differences was evaluated using the
two-way ANOVA test followed by Tukey’s multiple comparisons test. The statistical significance of the differences in parameter values
between specific time points (compared groups indicated with arrows) for guinea pigs infected with an equal amount of C. caviae is
indicated as follows: * P<0.05, ** P<0.005, and *** P<0.001.
https://doi.org/10.1371/journal.pone.0180551.g007
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capabilities of anti-chlamydial antibodies [34–38] and in vivo data showing anti-chlamydial
IgA in tears and vaginal washes [39–41] post-infection. In this study, ocular C. caviae infec-
tion significantly enhanced the production of C. caviae-specific IgA in tears with all inocula-
tion doses.
The local increase in C. caviae-specific IgA levels occurred at the beginning of the post-
infection period, on dpi4, and was transient. A period of 4 days after infection is insufficient
for the development of specific class switched primary response, and these findings may be
explained by the polyclonal activation of B cells locally present under physiological conditions
[7, 42]. As with other infections [20, 43, 44], a rapid rise in C. caviae-specific IgA levels may
imply stimulation of B cells already present in CALT to secrete antibodies that, due to cross-
reactivity [45], recognise chlamydial antigens. Therefore, the IgA response to C. caviae may be
affected by conjunctival B cells stimulated by ocular surface microbiome to develop a pre-
infection pool of B cells cross-reactive with C. caviae proteins.
As the beginning of the post-infection period is characterised by the development of an
inflammation-mediated pathology, also present in the 1×102 IFU per eye inoculated dose, we
hypothesised that the initial decrease in C. caviae-specific IgA production resulted from the
inflammatory milieu due to neutrophil influx. It has been postulated that neutrophils may
downregulate IgA humoral responses in ocular chlamydial infections, most likely by downre-
gulating TGF-β and IL-5 as both are increased when neutrophils are depleted, and both are
required for IgA production [20]. However, we were not able to test this hypothesis as the cyto-
kine consumables for the guinea pigs were unavailable.
The kinetics of systemic IgA- and IgG-mediated immune responses with moderate and
high infectious doses are indicative of an antigen-driven process and the development of spe-
cific adaptive immunity. Furthermore, if we take into account that specific IgG in tears is
most likely to be derived from a systemic response [30, 46], the reduction in specific IgA
local concentration prior to infection resolution may be compensated for by specific IgG
production.
In addition to the appearance of chlamydial antigen-specific antibodies, another immuno-
logic sign of chlamydial infection is the promotion of a proliferative response within the drain-
ing lymph node cells upon in vitro chlamydial stimulation [47]. Not surprisingly, on dpi4 there
were no proliferative responses in SMLN cells collected from guinea pigs infected with all
three infectious doses. Since these are primary cellular responses within 4 days of the infection,
SMLN cells were either in an unresponsive phase very close to initial stimulation, or there had
been insufficient time for a primary expansion. The C. caviae-specific proliferative responses
detected in draining SMLN cells obtained on dpi7 and dpi14 for medium and high doses, but
not for low doses, imply the development of specific immune response. It seems that low infec-
tious doses are not sufficiently effective to trigger the specific cellular immune response.
A number of studies highlight the role of CD8+ cells in response to chlamydial infection
[48–53]. It has also been suggested that local anti-chlamydial CD8+ cytotoxic T lymphocytes
may be important in the resolution of naturally acquired human ocular chlamydial infections
[54]. Furthermore, studies on animal models have shown that local CD4+ cell response via the
secretion of IFNγ and stimulation of other protective immune cells is required for a successful
resolution of chlamydial infection [55, 56].
In our experiment, unlike moderate and high C. caviae doses, low doses did not signifi-
cantly alter CD4+ and CD8+ cells within guinea pig SMLNs. These findings also suggest that
inoculation with 1×102 IFU of C. caviae is less effective in the activation of the cellular immune
response. This may be explained by the model proposed by Levitt et al. [7], suggesting that
local or systemic infection with relatively low numbers of Chlamydia may result in stimulation
of suppressor T cells, which can reduce both B cell proliferation and T helper cell activity and
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lead to down-regulation of the initial immune response. Moreover, responses to antigens pre-
sented during these periods may either be augmented (during early infection) or depressed
(during later infection). The significant, albeit not strong, negative correlation between pathol-
ogy intensity and percentage of CD4+ and CD8+ cells in the lymphocyte pool of SMLNs was
recorded for moderate and high but not for the low chlamydial infectious doses. The begin-
ning of the resolution of infection on dpi7 coincided with a significant drop in the frequency
of CD4+ and CD8+ lymphocytes in draining lymph nodes implying that the efflux of activated
CD4+ and CD8+ lymphocytes may be one of the explanations for the temporary drop in the
percentage of CD4+ and CD8+ lymphocytes within the SMLN.
IFNγ, one of the key cytokines of Th1 responses, is important in the control of chlamydial
infections via several well-described mechanisms [57]. It has been shown that peripheral blood
mononuclear cells from individuals where trachoma is endemic proliferate and produce IFNγ,
in response to chlamydial antigens, and these responses were weaker in subjects with tracho-
matous scarring when the antigens were absent [58]. Furthermore, IFNγ is increased in the
conjunctivae of affected individuals during active chlamydial infection [59].
Although antigen-specific IFNγ has been shown to be critical for protection against chla-
mydial infections, we did not observe any differences in IFNγ levels in tears between C. caviae
infected and control animals (S1 Fig). In genital chlamydia models, it has been shown that the
enhancement of TNFα is also required for achieving protection against chlamydia [60, 61] and
mechanisms that are nearly IFNγ independent but dependent on Plac8 and likely on T cell
degranulation exist as well [62]. Whether these mechanisms also apply to ocular chlamydial
infections should be further investigated.
Our results are consistent with those of previous studies in other chlamydial animal models,
which demonstrated that high infectious doses activate the immune response. In our study,
low doses of C. caviae were not able to effectively trigger either the specific cellular immune
response or the systemic humoral immune response. Primary ocular infection with low doses
induces polyclonal activation and is likely to stimulate parts of the innate immune response.
Further studies using these three distinct infectious doses are needed to elucidate the long-
term immune responses and protection in repeated chlamydial infections.
Supporting information
S1 Fig. The levels of IFNγ in the tears of guinea pigs infected with a single ocular instilla-
tion of three different C. caviae doses. The amount of C. caviae applied per guinea pig eye
(expressed in IFU) and screening time points within post-infection period (day 4 –dpi4, day 7
–dpi7, day 14 –dpi14, day 21 –dpi21) are indicated on the x-axis. The start of infection is con-
sidered as day 0. The age-matched non-infected guinea pigs (nc) were used as a negative con-
trol. IFNγ concentration was determined by ELISA (Cusabio Biotech, Baltimore, USA)
according to manufacturer’s instructions. The statistical significance of the observed differ-
ences was evaluated using the two-way ANOVA test followed by Tukey multiple comparisons
test. No statistically significant differences were recorded.
(TIF)
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